SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042635
Filing Date
2019-11-12
Accepted
2019-11-12 08:44:52
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-10q_20190930.htm 10-Q 2281183
2 EX-31.1 sybx-ex311_8.htm EX-31.1 16852
3 EX-31.2 sybx-ex312_7.htm EX-31.2 16795
4 EX-32.1 sybx-ex321_9.htm EX-32.1 6849
5 EX-32.2 sybx-ex322_10.htm EX-32.2 6832
  Complete submission text file 0001564590-19-042635.txt   7446045

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sybx-20190930.xml EX-101.INS 1554277
7 XBRL TAXONOMY EXTENSION SCHEMA sybx-20190930.xsd EX-101.SCH 52054
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sybx-20190930_cal.xml EX-101.CAL 69314
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sybx-20190930_def.xml EX-101.DEF 163437
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20190930_lab.xml EX-101.LAB 420893
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20190930_pre.xml EX-101.PRE 329093
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 191206404
SIC: 2834 Pharmaceutical Preparations